Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Umbilical Cord Blood Treatment for Refractory Immune Cytopenia: a Single-arm Prospective Study

NCT04420494 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.

NCT NCT04420494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04420494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Umbilical Cord Blood Treatment for Refractory Immune Cytopenia: a Single-arm Prospective Study
Lead sponsor
Peking Union Medical College Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
April 20, 2022
Completion date
April 20, 2022
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

refractory immune cytopenia, umbilical cord blood